麻豆传媒

Geriatrics >

Atherosclerosis

News, opinions and meeting coverage in geriatrics.

Cath Lab Recap: Killer Pacemakers; Heart Monitoring Underwear

Interventional cardiology news to note

AHA: Unnecessary Stress Testing Still Alive And Kicking?

More tests given to younger patients in large population study

AHA: Lower Better for Plaque Regression with PCSK9 Drugs

No diminishing returns at very low LDL levels in GLAGOV trial

TCT: Orsiro No Better Than EES for CTO

Also, injectable collagenase eases PCI for CTO in trial

TCT: Trials Split on PCI vs CABG for Left Main Disease

NOBLE hands advantage to surgery, EXCEL finds noninferiority

TCT: OCT Guidance Doesn't Undersize Stents, Trial Shows

Also found dissection, malapposition that IVUS missed

CardioBrief: LDL-Lowering Genetic Variants Linked to Diabetes Risk

What can genetics tell about diabetes incidence with cholesterol tx?

CardioBrief: Trump's CV Event Risk Seven Times Bigger Than Clinton's

Cardiologist speculates on coronary calcium scores disclosed by the candidates

The Lancet Versus BMJ: A Dispatch From the Statin Wars

The editors of the two top U.K. medical journals are in a bitter fight

ESC: Medical Therapy Adequate for Plaque Erosion

Pilot study suggests stenting not needed in uncomplicated cases

ESC: Winners Emerge in CAD Imaging Showdowns

Promising results for cardiac MRI, MPS, and PET

ACC: Looking Beyond Statins in LDL Lowering

New ACC guidance maps a path

Compression Stockings; Stroke Prevention; Stents and Meds

Cardiovascular Daily wraps up the top cardiology news of the week

ACC: Placebo Challenge for Statin Intolerance?

Cardiologists debate whether strategy might work in the clinic too

CNN Calls Out 'Cataract Risk' in HOPE-3

Statins and cataracts: So what?

ACC: After a Decade, CABG Pulls Ahead of Meds for HF

Life-saving benefit of CABG now clear in long-term trial follow-up

ACC: Evolocumab May Be Best Option for Statin Intolerance

Far greater LDL reduction but still some muscle complaints in GAUSS-3 trial

ACC: HOPE Results Boost Statin Prevention Role

Mortality and nonfatal events reduced

CardioBrief: New Thinking on Primary Prevention, Death, and Statins

Could lifetime benefit replace 10-year cardiovascular risk in shared decision-making?

When "Unremarkable" Is Not Clear Enough

Radiology reports need to be held to higher standards, argues Saurabh Jha, MD

Stroke Rounds: Nonstenosing Carotid Plaque Linked to Stroke

Implications for secondary prevention, study authors say

Immune Globulin: First for Severe Statin Reaction?

Small case study supports not waiting in statin-triggered autoimmune myopathy

Guidelines Issued for Managing Temperature During CBP

Clinicians now have officially sanctioned procedures to follow

FDA Approves First PCSK9 Inhibitor

Indication given for heterozygous HF and secondary prevention

Smoking After Stenting Ups Chest Pain

Post-PCI angina more common among smokers.

CardioBreak: Modern Bloodletting, a New Statin Strategy

Recent developments of interest in cardiovascular medicine.

Mild Stenosis Linked to Death in Diabetes

Long-term registry shows impact similar to single-vessel obstruction.

Atherosclerosis a Signal for Brain Drain?

Plaque burden was linked to cognitive impairment in a population-based study.

Patients Should Share Accountability for Own Health

A new report recommends doctors not be penalized for poor outcomes if patients fail to follow recommended protocols

How To Get Medicare To Cover A Spa Trip

Good news for doctors who think their patients need a trip to the spa: Medicare will reimburse, with only two catches.

Fatty Liver Tied to Diabetes, Atherosclerosis

LONDON -- Non-alcoholic fatty liver disease (NAFLD) is an independent predictor of both type 2 diabetes and carotid atherosclerosis, according to two studies presented here at the annual meeting of the European Association for the Study of the Liver.

ACC: Statins Tied to Boost in Men's Sexual Function

WASHINGTON -- Statins appeared to improve erectile function to a clinically meaningful degree, according to a meta-analysis.

Is There a Flaw in This Large Vitamin D Trial?

A co-principal investigator of the VITAL trial addresses the possibility that out-of-study testing of vitamin D levels and initiation of high-dose supplementation could be a limitation, but not a serious one.

CardioBuzz: More Money Needed for Heart Research?

The NIH dedicates a lot of money for research into heart disease and stroke, but it still might not be enough, a new study suggested.

FDA Flags Risk of Nuclear Stress Test Drugs

SILVER SPRING, Md. -- Two agents used in cardiac nuclear stress tests may carry a greater risk of heart attack and death than previously believed, the FDA said Wednesday.

New Nerve Tracer Not Ready for Routine Use?

CHICAGO -- The radiotracer iodine-123-metaiodobenzylguanidine may be a new tool for cardiac imaging, but whether it's ready for routine use in most practices was debated by nuclear cardiologists here.

Lab Notes: Meth May Worsen Fungal Infection

Mice injected with methamphetamine and exposed to Cryptococcus fungi showed more extensive and hard-to-eradicate infections. Also this week: an organic pesticide fights parasitic worms.

Zilver Stent Recalled, System May Break

Cook Medical's Zilver PTX drug-eluting stent for peripheral artery disease has been recalled because of a defect in its associated delivery system, the company and the FDA said.

Engineers Turn Fat into Blood Vessels

Liposuction can provide the raw materials for growing new small-diameter blood vessels in the lab, researchers found.

Doctors Say 45 Common Tests 'Overused'

Nine specialty groups have listed tests and treatments that are frequently overused, such as antibiotics for sinus attacks and CT scans for low back pain, in the first phase of a long-term project.

鈥�

7